http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102887834-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4827ad278df426e5e569d83ec2c51d6e |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C249-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C251-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 |
filingDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5c3e37b733fa64a216ac281e0406657 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e15f36f9901fc9a94145ee72ff6deb7a |
publicationDate | 2013-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102887834-A |
titleOfInvention | 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetone oxime and its application |
abstract | The invention discloses a 1-[4-[3-amino-4-hydroxy-3-(hydroxymethyl)butyl]phenyl]-1-acetone oxime and its application. The invention is based on the structure-activity of FTY720 According to the analysis, 1-[4-[3-amino-4-hydroxyl-3-(hydroxymethyl)butyl]phenyl]-1-acetone oxime was successfully synthesized. It can be used to prepare drugs and/or immunosuppressant drugs for the treatment of lung injury and/or pulmonary fibrosis, and provide a more effective and safer alternative drug for the treatment of lung injury and pulmonary fibrosis, which has the formula (1 ) or a salt thereof: |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113480455-A |
priorityDate | 2011-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465265244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163637267 |
Total number of triples: 17.